We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$9.81M
Cap. Flow
+$3.88M
Cap. Flow %
2.93%
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7
Avg Time Held Equity + Options
8.3 quarters
Top 10 Avg Time Held Equity + Options
4.3 quarters
Top 20 Avg Time Held Equity + Options
6.8 quarters
Avg Time Held Equity only
8.3 quarters
Top 10 Avg Time Held Equity only
4.3 quarters
Top 20 Avg Time Held Equity only
6.8 quarters

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.63M
2
META icon
Meta Platforms (Facebook)
META
+$1.55M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.29M
4
KKR icon
KKR & Co
KKR
+$941K
5
OHI icon
Omega Healthcare
OHI
+$856K

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$1.73M
2
YHOO
Yahoo Inc
YHOO
+$830K
3
JCI icon
Johnson Controls International
JCI
+$821K
4
SE icon
Spectra Energy Corp Wi
SE
+$571K
5
TPR icon
Tapestry
TPR
+$462K

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.21%
2 Real Estate 16.84%
3 Healthcare 12.91%
4 Technology 12.84%
5 Financials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BKTI icon
1
BK Technologies
BKTI
$272M
$8.88M 6.71%
332,690
+3,300
+1% +$88.7K
2013 Q2
13 quarters
GM icon
2
General Motors
GM
$72.3B
$5.01M 3.78%
157,693
-2,600
-2% -$81.2K
2014 Q3
8 quarters
BMY icon
3
Bristol-Myers Squibb
BMY
$118B
$4.38M 3.3%
81,159
+20,125
+33% +$1.29M
2013 Q3
12 quarters
PFE icon
4
Pfizer
PFE
$162B
$4.05M 3.06%
126,110
-1,054
-0.8% -$35.2K
2013 Q2
13 quarters
META icon
5
Meta Platforms (Facebook)
META
$1.89T
$3.58M 2.7%
27,880
+12,500
+81% +$1.55M
2013 Q3
12 quarters
HTGC icon
6
Hercules Capital
HTGC
$3.1B
$3.45M 2.6%
254,111
-1,100
-0.4% -$14.7K
2013 Q2
13 quarters
PHYS icon
7
Sprott Physical Gold
PHYS
$14.9B
$3.03M 2.29%
276,671
– –
2013 Q2
13 quarters
MDLZ icon
8
Mondelez International
MDLZ
$78.9B
$3M 2.27%
68,433
-2,900
-4% -$127K
2013 Q2
13 quarters
ABR icon
9
Arbor Realty Trust
ABR
$528M
$2.92M 2.21%
394,083
+300
+0.1% +$2.22K
2013 Q2
13 quarters
SPA
10
DELISTED
Sparton
SPA
$2.85M 2.15%
108,524
-900
-0.8% -$20.7K
2013 Q2
13 quarters
MSFT icon
11
Microsoft
MSFT
$4.02T
$2.66M 2.01%
46,165
+850
+2% +$48K
2013 Q2
13 quarters
MPT icon
12
Medical Properties Trust
MPT
$1.88B
$2.65M 2%
179,700
-1,200
-0.7% -$18.2K
2015 Q2
5 quarters
C icon
13
Citigroup
C
$221B
$2.64M 1.99%
55,830
-640
-1% -$29.1K
2014 Q3
8 quarters
CLNY
14
DELISTED
Colony Capital, Inc.
CLNY
$2.6M 1.97%
142,867
+1,600
+1% +$28.3K
2013 Q2
13 quarters
AERI
15
DELISTED
Aerie Pharmaceuticals
AERI
$2.38M 1.8%
63,200
+8,500
+16% +$187K
2014 Q3
8 quarters
TOWN icon
16
Towne Bank
TOWN
$3.24B
$2.33M 1.76%
97,082
-3,200
-3% -$74.2K
2014 Q4
7 quarters
TPR icon
17
Tapestry
TPR
$23.4B
$2.27M 1.71%
61,970
-11,650
-16% -$462K
2013 Q2
13 quarters
SIR
18
DELISTED
SELECT INCOME REIT
SIR
$2.26M 1.71%
191,214
-2,047
-1% -$24.3K
2014 Q2
9 quarters
CVA
19
DELISTED
Covanta Holding Corporation
CVA
$2.12M 1.6%
137,876
-2,400
-2% -$37.3K
2014 Q4
7 quarters
RLH
20
DELISTED
Red Lions Hotel Corporation
RLH
$2.05M 1.54%
245,350
+13,026
+6% +$95.8K
2013 Q2
13 quarters
VOLT icon
21
DELISTED
Volt Information Sciences, Inc.
VOLT
$1.96M 1.48%
308,481
+30,886
+11% +$191K
2014 Q3
8 quarters
KKR icon
22
KKR & Co
KKR
$82.1B
$1.93M 1.46%
135,408
+66,327
+96% +$941K
2014 Q2
9 quarters
MFA icon
23
MFA Financial
MFA
$675M
$1.92M 1.45%
64,256
+2,025
+3% +$61.4K
2013 Q2
13 quarters
CIM icon
24
Chimera Investment
CIM
$733M
$1.92M 1.45%
40,107
+5,567
+16% +$272K
2014 Q1
10 quarters
B icon
25
Barrick Mining
B
$67.2B
$1.91M 1.44%
107,500
– –
2016 Q2
1 quarter
1
2 3 4 5

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.

  • Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
  • Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
  • Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
  • Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
  • Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.